Literature DB >> 20937823

High mobility group box 1 release from hepatocytes during ischemia and reperfusion injury is mediated by decreased histone deacetylase activity.

John Evankovich1, Sung W Cho, Ruilin Zhang, Jon Cardinal, Rajeev Dhupar, Lemeng Zhang, John R Klune, Jason Zlotnicki, Timothy Billiar, Allan Tsung.   

Abstract

The mobilization and extracellular release of nuclear high mobility group box-1 (HMGB1) by ischemic cells activates inflammatory pathways following liver ischemia/reperfusion (I/R) injury. In immune cells such as macrophages, post-translational modification by acetylation appears to be critical for active HMGB1 release. Hyperacetylation shifts its equilibrium from a predominant nuclear location toward cytosolic accumulation and subsequent release. However, mechanisms governing its release by parenchymal cells such as hepatocytes are unknown. In this study, we found that serum HMGB1 released following liver I/R in vivo is acetylated, and that hepatocytes exposed to oxidative stress in vitro also released acetylated HMGB1. Histone deacetylases (HDACs) are a family of enzymes that remove acetyl groups and control the acetylation status of histones and various intracellular proteins. Levels of acetylated HMGB1 increased with a concomitant decrease in total nuclear HDAC activity, suggesting that suppression in HDAC activity contributes to the increase in acetylated HMGB1 release after oxidative stress in hepatocytes. We identified the isoforms HDAC1 and HDAC4 as critical in regulating acetylated HMGB1 release. Activation of HDAC1 was decreased in the nucleus of hepatocytes undergoing oxidative stress. In addition, HDAC1 knockdown with siRNA promoted HMGB1 translocation and release. Furthermore, we demonstrate that HDAC4 is shuttled from the nucleus to cytoplasm in response to oxidative stress, resulting in decreased HDAC activity in the nucleus. Together, these findings suggest that decreased nuclear HDAC1 and HDAC4 activities in hepatocytes following liver I/R is a mechanism that promotes the hyperacetylation and subsequent release of HMGB1.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20937823      PMCID: PMC3000970          DOI: 10.1074/jbc.M110.128348

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

1.  Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion.

Authors:  Tiziana Bonaldi; Fabio Talamo; Paola Scaffidi; Denise Ferrera; Annalisa Porto; Angela Bachi; Anna Rubartelli; Alessandra Agresti; Marco E Bianchi
Journal:  EMBO J       Date:  2003-10-15       Impact factor: 11.598

Review 2.  Histone deacetylases: salesmen and customers in the post-translational modification market.

Authors:  André Brandl; Thorsten Heinzel; Oliver H Krämer
Journal:  Biol Cell       Date:  2009-04       Impact factor: 4.458

Review 3.  Histone deacetylases (HDACs): characterization of the classical HDAC family.

Authors:  Annemieke J M de Ruijter; Albert H van Gennip; Huib N Caron; Stephan Kemp; André B P van Kuilenburg
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

4.  Histone deacetylase 4 possesses intrinsic nuclear import and export signals.

Authors:  A H Wang; X J Yang
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

5.  Duration of nuclear NF-kappaB action regulated by reversible acetylation.

Authors:  W Fischle; E Verdin; W C Greene
Journal:  Science       Date:  2001-08-31       Impact factor: 47.728

6.  The histone-deacetylase inhibitor Trichostatin A blocks proliferation and triggers apoptotic programs in hepatoma cells.

Authors:  Christoph Herold; Marion Ganslmayer; Matthias Ocker; Martin Hermann; Albert Geerts; Eckhart G Hahn; Detlef Schuppan
Journal:  J Hepatol       Date:  2002-02       Impact factor: 25.083

7.  Histone deacetylase 1 phosphorylation promotes enzymatic activity and complex formation.

Authors:  M K Pflum; J K Tong; W S Lane; S L Schreiber
Journal:  J Biol Chem       Date:  2001-10-15       Impact factor: 5.157

8.  Release of chromatin protein HMGB1 by necrotic cells triggers inflammation.

Authors:  Paola Scaffidi; Tom Misteli; Marco E Bianchi
Journal:  Nature       Date:  2002-07-11       Impact factor: 49.962

9.  Trichostatin A induces differential cell cycle arrests but does not induce apoptosis in primary cultures of mitogen-stimulated rat hepatocytes.

Authors:  Peggy Papeleu; Pascal Loyer; Tamara Vanhaecke; Greetje Elaut; Albert Geerts; Christiane Guguen-Guillouzo; Vera Rogiers
Journal:  J Hepatol       Date:  2003-09       Impact factor: 25.083

10.  HMGB1 develops enhanced proinflammatory activity by binding to cytokines.

Authors:  Yonggang Sha; Jaroslaw Zmijewski; Zhiwei Xu; Edward Abraham
Journal:  J Immunol       Date:  2008-02-15       Impact factor: 5.422

View more
  109 in total

Review 1.  HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease.

Authors:  Helena Erlandsson Harris; Ulf Andersson; David S Pisetsky
Journal:  Nat Rev Rheumatol       Date:  2012-01-31       Impact factor: 20.543

Review 2.  Regulation of Posttranslational Modifications of HMGB1 During Immune Responses.

Authors:  Yiting Tang; Xin Zhao; Daniel Antoine; Xianzhong Xiao; Haichao Wang; Ulf Andersson; Timothy R Billiar; Kevin J Tracey; Ben Lu
Journal:  Antioxid Redox Signal       Date:  2016-02-05       Impact factor: 8.401

Review 3.  Contributions of nonhematopoietic cells and mediators to immune responses: implications for immunotoxicology.

Authors:  Barbara L F Kaplan; Jinze Li; John J LaPres; Stephen B Pruett; Peer W F Karmaus
Journal:  Toxicol Sci       Date:  2015-06       Impact factor: 4.849

4.  Impact of intestinal ischemia/reperfusion and lymph drainage on distant organs in rats.

Authors:  Gui-Zhen He; Kai-Guo Zhou; Rui Zhang; Yu-Kang Wang; Xue-Feng Chen
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

5.  DAP12 expression in lung macrophages mediates ischemia/reperfusion injury by promoting neutrophil extravasation.

Authors:  Jessica H Spahn; Wenjun Li; Alejandro C Bribriesco; Jie Liu; Hua Shen; Aida Ibricevic; Jie-Hong Pan; Bernd H Zinselmeyer; Steven L Brody; Daniel R Goldstein; Alexander S Krupnick; Andrew E Gelman; Mark J Miller; Daniel Kreisel
Journal:  J Immunol       Date:  2015-03-11       Impact factor: 5.422

6.  HMGB1 recruits hepatic stellate cells and liver endothelial cells to sites of ethanol-induced parenchymal cell injury.

Authors:  Yeon S Seo; Jung H Kwon; Usman Yaqoob; Liu Yang; Thiago M De Assuncao; Douglas A Simonetto; Vikas K Verma; Vijay H Shah
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-10-03       Impact factor: 4.052

7.  JAK/STAT1 signaling promotes HMGB1 hyperacetylation and nuclear translocation.

Authors:  Ben Lu; Daniel J Antoine; Kevin Kwan; Peter Lundbäck; Heidi Wähämaa; Hanna Schierbeck; Melissa Robinson; Marieke A D Van Zoelen; Huan Yang; Jianhua Li; Helena Erlandsson-Harris; Sangeeta S Chavan; Haichao Wang; Ulf Andersson; Kevin J Tracey
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-27       Impact factor: 11.205

Review 8.  Regulation of HMGB1 release by inflammasomes.

Authors:  Ben Lu; Haichao Wang; Ulf Andersson; Kevin J Tracey
Journal:  Protein Cell       Date:  2013-03-13       Impact factor: 14.870

9.  Complementary induction of immunogenic cell death by oncolytic parvovirus H-1PV and gemcitabine in pancreatic cancer.

Authors:  Assia L Angelova; Svitlana P Grekova; Anette Heller; Olga Kuhlmann; Esther Soyka; Thomas Giese; Marc Aprahamian; Gaétan Bour; Sven Rüffer; Celina Cziepluch; Laurent Daeffler; Jean Rommelaere; Jens Werner; Zahari Raykov; Nathalia A Giese
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

10.  Alarmin high-mobility group B1 (HMGB1) is regulated in human adipocytes in insulin resistance and influences insulin secretion in β-cells.

Authors:  R Guzmán-Ruiz; F Ortega; A Rodríguez; R Vázquez-Martínez; A Díaz-Ruiz; S Garcia-Navarro; M Giralt; A Garcia-Rios; D Cobo-Padilla; F J Tinahones; J López-Miranda; F Villarroya; G Frühbeck; J M Fernández-Real; M M Malagón
Journal:  Int J Obes (Lond)       Date:  2014-02-28       Impact factor: 5.095

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.